Two small studies in IBD (26,27) showed an increase in body weight with all biologics (anti-TNFα, vedolizumab, ustekinumab); however, ustekinumab was not associated with statistically significant weight gain compared with anti-TNFα and vedolizumab in one of these studies (27). The gene discussed is TNF; the disease is inflammatory bowel disease.